Marillion Pharmaceuticals marillionpharma.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1146)

Marillion Pharmaceuticals, Inc. - Marillion is developing clinical-stage drugs in oncology and oncology supportive care. 177Lu-AMBA is a targeted radiotherapeutic, with the low level radiation of lutetium that aims to utilize an receptor-based technology, and can serve as both a diagnostic and therapeutic agent. The targeting capability means that 177Lu-AMBA homes in on tumor cells and spares normal tissues. 177Lu-AMBA is being pursued initially to treat hormone-resistant prostate cancer, ha...Show all

Marillion Pharmaceuticals, Inc. - Marillion is developing clinical-stage drugs in oncology and oncology supportive care. 177Lu-AMBA is a targeted radiotherapeutic, with the low level radiation of lutetium that aims to utilize an receptor-based tech...Show all

Company (Alive / Active)

Phone: 484-875-3018

Fax:

102 Pickering Way
Suite 200
Exton, 19341
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Marillion Pharmaceuticals $2M Feb 4, 2006
See all 37 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Marillion Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Novalar Pharmaceuticals

San Diego, California, United States
Alive / ActiveNovalar is developing a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures, thereby allowing patients to return to their daily activities without the speech impediments, lip biting, and difficulty in eating that can be caused by unintended soft-tissue anesthesia.Login to see details

OncoMed Pharmaceuticals

Redwood City, California, United States
AcquiredOncoMed Pharmaceuticals is a clinical-stage company focused on discovering and developing therapeutics targeting cancer stem cells, or CSCs, which are the subpopulation of cells in a tumor responsible for driving growth and metastasis of the tumor.Login to see details
See all 37 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)